RxDoctor Payments Data

Gary McPhail

Pediatric Pulmonology · Cincinnati, OHNPI 1821027483

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (44.1%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Boehringer Ingelheim accounts for 62.6% of it on its own, with 3 other manufacturers making up the rest.

$1,572in general payments, 2019–2025

Across 10 payments — averaging $157.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$984
  • Vertex$555
  • Alcresta Therapeutics, Inc.$18
  • AbbVie$16
$1,081,260in research payments, 2019–2025

Across 59 payments — averaging $18,326 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Vertex$1.1M
  • Boehringer Ingelheim$17K
  • Boehringer Ingelheim France S.a.s.$3K
  • Boehringer Ingelheim International GmbH$861

What the payments were for

  • Consulting fees$55535%
  • Travel & lodging$69444%
  • Food & beverage$32421%

General payments by program year

19
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,572 in reported general payments places this provider in the 75th percentile of 68 pediatric pulmonology providers in Ohio.

See all pediatric pulmonology providers in Ohio

Other pediatric pulmonology in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →